Sirona, an oral gastro-retentive hydrogel, is well tolerated, leading only to mild gastrointestinal side effects, and produces sustained reductions in body weight and dietary intake. Overall, 29 ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

UBS lowered the firm’s price target on Dentsply Sirona (XRAY) to $23 from $24 and keeps a Buy rating on the shares. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, ...

Get the annual and quarterly balance sheet of DENTSPLY SIRONA Inc. (XRAY) including details of assets, liabilities and shareholders' equity.

Schick Technologies brings a new level of freedom and flexibility to dental digital radiography with Schick WiFi. Building on Schick CDR Elite's industry-leading CMOS-APS platform, it combines leading ...

Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, combining leading platforms spanning consumables, equipment, technology, and specialty products.

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.

Sirolimus-coated balloons were noninferior to paclitaxel-coated balloons in terms of safety and efficacy in treating patients with femoropopliteal artery disease, based on findings from the ...